Special considerations in assisted reproductive technology for patients with hematologic disease.

Abstract

Populations with hematologic disorders seeking fertility care often present with a complex clinical picture, including disease-specific sequelae and comorbid conditions. Limited literature exists to help guide fertility clinics on the management of these patients, many of whom require multidisciplinary care coordination centered on patient-specific fertility goals. Thanks to advancements in life-prolonging therapies for hematologic disorders, growing numbers of affected individuals are seeking assisted reproductive technologies (ART) for family building. Thus, it is important to be aware of the unique considerations and risks of ART for these populations and develop evidence-based care guidelines to optimize outcomes.